O-GlcNAcylation was augmented in c-Myc transgenic mice where cardiac hypertrophy was induced (41), whereas elevated O-GlcNAcylation after TAC was blunted in c-Myc knockout mice where cardiac hypertrophy was attenuated (42). The gene discussed is MYC; the disease is cardiac hypertrophy.